Cerebral Vein and Dural Venous Sinus Thrombosis: Risk Factors, Prognosis and Treatment—a Modern Approach

REFERENCES

• Masuhr F, Mehraein S, Einhaupl K. Cerebral venous and sinus thrombosis. J Neurol 2004;251:11–23.
   PubMed Web of Science ®Google Scholar
• Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005;352:1791–1798.
   PubMed Web of Science ®Google Scholar
• Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664–670.
   PubMed Web of Science ®Google Scholar
• Wasay M, Bakshi R, Bobustuc G, Kojan S, Sheikh Z, Dai A, Cheema Z. Cerebral venous thrombosis: Analysis of a multicenter cohort from the United States. J Stroke Cerebrovasc Dis 2008;17:49–54.
   PubMedGoogle Scholar
• Giroud M, Gras P, Fayolle H, André N, Soichot P, Dumas R. Early seizures after acute stroke: A study of 1,640 cases. Epilepsia 1994;35:959–964.
   PubMed Web of Science ®Google Scholar
• van den Bergh WM, van der Schaaf I, van Gijn J. The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis. Neurology 2005;65:192–196.
   Google Scholar
• Sébire G, Tabarki B, Saunders DE, Leroy I, Liesner R, Saint-Martin C, Husson B, Williams AN, Wade A, Kirkham FJ. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain 2005;128:477–489.
   PubMed Web of Science ®Google Scholar
• Dentali F, Gianni M, Crowther MA, WL Ageno. Natural history of cerebral vein thrombosis: A systematic review. Blood 2006;108(4)1129–1134.
   Google Scholar
• Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: A meta-analysis. Blood 2006;107:2766–2773.
   PubMed Web of Science ®Google Scholar
• Cantu C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases. Stroke 1993;24:1880–1884.
   PubMed Web of Science ®Google Scholar
• Canhão P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarrementeria F, Investigators ISCVT. Causes and predictors of death in cerebral venous thrombosis. Stroke 2005;36:1720–1725.
   PubMed Web of Science ®Google Scholar
• de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;30:484–488.
   PubMed Web of Science ®Google Scholar
• Girot M, Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, Leys D, ISCVT Investigators. Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke 2007;38:337–342.
   Google Scholar
• Stam J, Lensing AW, Vermeulen M, Tijssen JG. Heparin treatment for cerebral venous and sinus thrombosis. Lancet 1991;338(8775)1154.
   Google Scholar
• Agid R, Shelef I, Scott JN, Farb RI. Imaging of the intracranial venous system. Neurologist 2008;14(1)12–22.
   Google Scholar
• Leach JL, Fortuna RB, Jones BV, Gaskill-Shipley MF. Imaging of cerebral venous thrombosis: Current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics 2006;26(Suppl 1)S19–41 discussion S42–3.
   Google Scholar
• Khealani BA, Wasay M, Saadah M, Sultana E, Mustafa S, Khan FS, Kamal AK. Cerebral venous thrombosis: A descriptive multicenter study of patients in Pakistan and Middle East. Stroke 2008;39:2707–2711.
   PubMed Web of Science ®Google Scholar
• Panagariya A, Maru A. Cerebral venous thrombosis in pregnancy and puerperium–A prospective study. J Assoc Physicians India 1997;45:857–859.
   PubMedGoogle Scholar
• Wysokinska EM, Wysokinski WE, Brown RD, Karnicki K, Gosk-Beirska I, Grill D, McBane RD2nd. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology 2008;70:627–633.
   Google Scholar
• Carhuapoma JR, Mitsias P, Levine SR. Cerebral venous thrombosis and anticardiolipin antibodies. Stroke 1997;28:2363–2369.
   PubMed Web of Science ®Google Scholar
• de Bruijn SF, Stam J, Vandenbroucke JP. Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptives. Cerebral Venous Sinus Thrombosis Study Group. Lancet 1998;351:1404.
   PubMedGoogle Scholar
• Christopher R, Nagaraja D, Dixit NS, Narayanan CP. Anticardiolipin antibodies: A study in cerebral venous thrombosis. Acta Neurol Scand 1999;99:121–124.
   Google Scholar
• Deschiens MA, Conard J, Horellou MH, Ameri A, Preter M, Chedru F, Samama MM, Bousser MG. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke 1996;27:1724–1730.
   PubMed Web of Science ®Google Scholar
• Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhomocysteinemia in cerebral vein thrombosis. Blood 2003;102:1363–1366.
   PubMedGoogle Scholar
• Libourel EJ, ten Kate MK, Brouwer JL, Veeger NJ, van der Meer J. Contribution of multiple thrombophilic and transient risk factors in the development of cerebral venous thrombosis. Thrombosis research 2007;121:301–307.
   Google Scholar
• Gadelha T, André C, Jucá AA, Nucci M. Prothtombin 20210A and Oral Contraceptive Use as Risk Factors for Cerebral Venous Thrombosis. Cerebrovasc Dis 2005;19:49–52.
   PubMed Web of Science ®Google Scholar
• Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998;338:1793–1797.
   PubMed Web of Science ®Google Scholar
• Raizer JJ, DeAngelis LM. Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients. Neurology 2000;54:1222–1226.
   Google Scholar
• de Freitas GR, Bogousslavsky J. Risk Factors of Cerebral Vein and Sinus Thrombosis. Front Neurol Neurosci 2008;23:23–54.
   PubMedGoogle Scholar
• Ferro JM, Canhão P, Bousser MG, Stam J, Barinagarrementeria F, ISCVT Investigators. Early seizures in cerebral vein and dural sinus thrombosis: Risk factors and role of antiepileptics. Stroke 2008;39(4)1152–1158.
   Google Scholar
• De Stefano V, Fiorini A, Rossi E, Za T, Farina G, Chiusolo P, Sica S, Leone G. Incidence of JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders. J Thromb Haemost 2007;5:708–714.
   PubMedGoogle Scholar
• Einhaupl K, Bousser MG, de Bruijn SF, Ferro JM, Martinelli I, Masuhr F, Stam J. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol 2006;13:553–9.
   PubMed Web of Science ®Google Scholar
• Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ, American College of Chest Physician. Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:110S–112S.
   PubMed Web of Science ®Google Scholar
• Ray JG, Kearon C, Yi Q, Sheridan P, Lonn E. Heart Outcomes Prevention Evaluation 2 (HOPE-2) Investigators: Homocysteine-lowering therapy and risk for venous thromboembolism. Annals of Internal Medicine 2007;146:761–767.
   PubMedGoogle Scholar
• den Heijer M, Willems HP, Blom HJ, Gerrits WB, Cattaneo M, Eichinger S, Rosendaal FR, Bos GM. Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: A randomized, placebo-controlled, double-blind trial. Blood 2007;109:139–144.
   PubMed Web of Science ®Google Scholar
• Heit J., Thrombophilia. Common Questions on laboratory assessment and management. Hematology Am Soc Hematol Educ Program 2007:127–135.
   Google Scholar
• Rand JH. The antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program 2007:136–142.
   Google Scholar
• Bobba RS, Johnson SR, Davis AM. A review of the Sapporo and revised Sapporo criteria for the classification of antiphospholipid syndrome. Where do the revised Sapporo criteria add value?. J Rheumatol 2007;34:1522–1527.
   PubMed Web of Science ®Google Scholar
• Giannakopoulos B, Passam F, Ioannou Y, Krilis SA. How we diagnose the antiphospholipid syndrome. Blood 2009;113:985–994.
   PubMed Web of Science ®Google Scholar
• Garcia DA, Khamashta MA, Crowther MA. How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: A case-based review. Blood 2007;110:3122–3127.
   PubMed Web of Science ®Google Scholar
• Stam J, De Bruijn SF, DeVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev. 2002 ;(4): CD002005.
   PubMedGoogle Scholar
• van Dongen CJ, van den Belt AG, Prins MH, Lensing AW. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Conchrane Database Syst Rev 2004;18(4) CD001100.
   Google Scholar
• Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ. American College of Chest Physicians. Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:71S–109S.
   PubMed Web of Science ®Google Scholar
• Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993–997.
   PubMed Web of Science ®Google Scholar
• Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P; American College of Chest Physicians. Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:630–669.
   PubMedGoogle Scholar
• Martinelli I, Franchini M, Mannucci PM. How I treat rare venous thromboses. Blood 2008;112:4818–4823.
   Google Scholar
• Warkentin TE, Greinacher A, Koster A, Lincoff AM, American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:340S–380S.
   PubMed Web of Science ®Google Scholar
• Keeling D, Davidson S, Watson H, Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. The management of heparin-induced thrombocytopenia. Br J Haematol 2006;133:259–269.
   PubMed Web of Science ®Google Scholar
• Stam J, Majoie CB, van Delden OM, van Lienden KP, Reekers JA. Endovascular Thrombectomy and Thrombolysis for Severe Cerebral Sinus Thrombosis: A Prospective Study. Stroke 2008;39:1487–1490.
   PubMed Web of Science ®Google Scholar
• Canhão P, Falcão F, Ferro JM. Thrombolytics for cerebral sinus thrombosis: A systemic review. Cerebrovascular Disease 2003;15:159–166.
   PubMed Web of Science ®Google Scholar
• Ciccone A, Canhão P, Falcão F, Ferro JM, Sterzi R. Thrombolysis for Cerebral Vein and Dural Sinus Thrombosis. Cochrane Database Syst Rev. 2004 (1):CD003693.
   Google Scholar
• Canhão P, Cortesao A, Cabral M, Ferro JM, Stam J, Bousser MG, Barinagarrementeria F, ISCVT Investigators. Are steroids useful to treat cerebral venous thrombosis?. Stroke 2008;39:105–110.
   PubMed Web of Science ®Google Scholar
• Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology 1999;53:1537–1542.
   PubMed Web of Science ®Google Scholar
• Ferro JM, Canhão P. Complications of cerebral vein and sinus thrombosis. Front Neurol Neurosci 2008;23:161–171.
   PubMedGoogle Scholar
• Purvin VA, Trobe JD, Kosmorsky G. Neuro-ophthalmic features of cerebral venous obstruction. Arch Neurol 1995;52:880–885.
   PubMedGoogle Scholar
• Ferro JM, Canhão P. Acute treatment of cerebral venous and dural sinus thrombosis. Curr Treat Options Neurol 2008;10:126–137.
   PubMedGoogle Scholar
• Biousse V, Tong F, Newman NJ. Cerebral Venous Thrombosis. Curr Treat Options Neurol 2003;5:409–420.
   PubMedGoogle Scholar
• Horton JC, Seiff SR, Pitts LH, Weinstein PR, Rosenblum ML, Hoyt WF. Decompression of the optic nerve sheath for vision-threatening papilledema caused by dural sinus occlusion. Neurosurgery 1992;31:203–211 discussion 211–212.
   Google Scholar
• Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000;31:1274–1282.
   PubMed Web of Science ®Google Scholar
• Mehraein S, Ortwein H, Busch M, Weih M, Einhäupl K, Masuhr F. Risk of recurrence of cerebral venous and sinus thrombosis during subsequent pregnancy and puerperium. J Neurol Neurosurg Psychiatry 2003;74:814–816.
   PubMedGoogle Scholar
• Lamy C, Hamon JB, Coste J, Mas JL. Ischemic stroke in young women: Risk of recurrence during subsequent pregnancies. French Study Group on Stroke in Pregnancy. Neurology 2000;55:269–274.
   PubMed Web of Science ®Google Scholar
• Mas JL, Lamy C. Stroke in pregnancy and the puerperium. J Neurol. 1998;245:305–313.
   PubMed Web of Science ®Google Scholar
• Preter M, Tzourio C, Ameri A, Bousser MG. Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke 1996;27:243–246.
   PubMed Web of Science ®Google Scholar
• Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy. Blood 2005;106:401–407.
   PubMed Web of Science ®Google Scholar
• Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. American College of Chest Physicians: Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:844S–886S.
   PubMed Web of Science ®Google Scholar
• Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980;68:122–140.
   PubMed Web of Science ®Google Scholar
• Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 2000;160:191–196.
   PubMedGoogle Scholar
• Bates SM. Management of pregnant women with thrombophilia or a history of venous thromboembolism. Hematology Am Soc Hematol Educ Program 2007:143–150.
   Google Scholar
• Gosk-Bierska I, Wysokinski W, Brown RDJr., Karnicki K, Grill D, Wiste H, Wysokinska E, McBane RD2nd. Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival. Neurology 2006;67:814–819.
   PubMedGoogle Scholar